Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 4/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | PPID | Q08752 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | MITF | O75030 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | P4HB | P07237 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17449944 | 0.87 | KDM4E (0.49) | LTA4HTSHRL3MBTL1ALDH1A1KDM4E | |
| SCHEMBL7366200 | 0.85 | KDM4E (0.53) | LTA4HKDM4EMEN1KMT2A | |
| SCHEMBL12770916 | 0.85 | LTA4H (0.58) | LTA4HTSHRTDP1L3MBTL1ALDH1A1 | |
| SCHEMBL27575333 | 0.85 | MEP1B (0.56) | LTA4HTSHRSMN1; SMN2KMT2A | |
| SCHEMBL75205 | 0.84 | PPID (0.69) | LTA4HPPIDALDH1A1SMN1; SMN2RECQL | |
| SCHEMBL17241222 | 0.83 | LTA4H (0.60) | LTA4HALDH1A1MAPK1KDM4ELMNA | |
| Hydrochloric Acid SCHEMBL3926946 | 0.83 | PPID (0.68) | LTA4HPPIDALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL7366849 | 0.83 | EPHX2 (0.56) | ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A | |
| SCHEMBL30909992 | 0.82 | SCN8A (0.51) | LTA4H | |
| SCHEMBL14793900 | 0.81 | PLA2G2A (0.46) | LTA4HTSHRPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11859018-B2 | Peptoid-based chelating ligands for selective metal chelation | TRIAD NATIONAL SECURITY, LLC (US) | 2024-01-02 | — | — | US | disclosed |
| US-20220135623-A1 | PEPTOID-BASED CHELATING LIGANDS FOR SELECTIVE METAL CHELATION | U.S. DEPARTMENT OF ENERGY | 2022-05-05 | — | — | US | disclosed |
| US-11254708-B2 | Peptoid-based chelating ligands for selective metal chelation | TRIAD NATIONAL SECURITY, LLC (US) | 2022-02-22 | — | — | US | disclosed |
| US-5861380-A | OXADIAZOLE, THIADIAZOLE AND TRIAZOLE PEPTOIDS AS INHIBITORS OF HUMAN NEUTROPHIL ELASTASE; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIARTHRITIC,-INFLAMMATORY,-ISCHEMIC,-TUMOR AND -CARCINOGENIC AGENTS AND OTHER HNE-MEDIATED CONDITIONS | CORTECH, INC. (US) | 1999-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220135623-A1 | PEPTOID-BASED CHELATING LIGANDS FOR SELECTIVE METAL CHELATION | SLC39A14, SLC39A11, SLC40A1 | LTA4H 2215/4885TSHR 660/4885TDP1 2722/4885 |
| US-11254708-B2 | Peptoid-based chelating ligands for selective metal chelation | SLC39A14, SLC39A11, SLC40A1 | LTA4H 2215/4885TSHR 660/4885TDP1 2722/4885 |
| US-11859018-B2 | Peptoid-based chelating ligands for selective metal chelation | SLC39A14, SLC39A11, SLC40A1 | LTA4H 2215/4885TSHR 660/4885TDP1 2722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.